http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1273113-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a606d10f9e101412b73e8f153cf89e71 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 1984-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1986-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab3b50f6700be4aa6ef7878c73e0f0a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d61b77df350c3965d74c87f3f614ef |
| publicationDate | 1986-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1273113-A1 |
| titleOfInvention | Method of treatment of chronic nonspecific ulcerative colitis |
| abstract | The invention relates to medicine, for the treatment of nonspecific ulcerative colitis. The purpose of the invention is to reduce the time of treatment by using freshly isolated donor leukocyte mass with a shelf life of not more than a day. The patient underwent colonofibroscopy, specifying the localization and prevalence of the lingual process. Then, an injection needle is inserted through the biofusion channel of the colonofibroscope, ulcerative defects are cut off with its help, starting with the rectum and passing to the higher sections, with the simultaneous introduction of 30 to 90 ml of freshly donated donated leykomassy. At the same time, oral treatment with oral sulphasalazyl is used. |
| priorityDate | 1984-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.